About 200 reports

  • IMMUNOLOGY THERAPEUTICS MARKET, GLOBAL, ANNUAL REVENUES FOR CIMZIA ($BN), 2006-2022
  • IMMUNOLOGY, GLOBAL, ANNUAL REVENUE FORECAST FOR UPADACITINIB ($M), 2015-2022

Gastrointestinal Cancer Research; ##(##): ##-## Mayo Clinic (2014).

  • Immunology
  • World
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Johnson & Johnson

Report Title Published Date ##.

  • Immunology
  • North America
  • United States
  • World
  • Horizon Discovery
  • Establish ed
  • 4.2 Key Therapy Areas by Indication

Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary Innovation is a crucial element of the pharmaceutical industry. The market is highly research-intensive, being deeply reliant on a high level of R&D investment and a strong product pipeline to maintain growth and...

  • Immunology
  • Pharmaceutical
  • Therapy
  • United States
  • Market Size
  • Pipeline Landscape Assessment

Excluded from this report are Crohn' s disease and ulcerative colitis, as they fall under the gastrointestinal disorders therapy area.

  • Immunology
  • World
  • Market Size
  • Johnson & Johnson
  • Novartis AG

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation
  • Central Nervous System
  • Research Contact: info@globaldata.com

Besides, one PE deal worth USD##m was recorded in Q## 2017.

  • Immunology
  • Neurology
  • World
  • Company
  • Deals & Alliance
  • Research Contact: info@globaldata.com

Besides, one VC deal worth USD##. ##m was reported in Q## 2016.

  • Endocrine Disease
  • Immunology
  • World
  • Company
  • Deals & Alliance
  • IMMUNOLOGY DRUGS MARKET, GLOBAL, ORGAN-SPECIFIC SYMPTOMS OF ACUTE GVHD, 2018
  • IMMUNOLOGY DRUGS MARKET, GLOBAL, ORGAN-SPECIFIC SYMPTOMS OF CHRONIC GVHD, 2018

Ulcerative colitis and CD are similar in that they are chronic, inflammatory gastrointestinal diseases, but they can be differentiated from one another by the location of the affected area of the gastrointestinal tract, and by the differences in histological features of th

  • Healthcare
  • Immunology
  • World
  • Company Financials
  • Forecast

In the AR## arm, ##. ##% of patients discontinued due to investigator-reported adverse events, including ##. ##% due to gastrointestinal adverse events and ##. ##% due to systemic allergic hypersensitivity reactions.

  • Clinical Trial
  • Immunology
  • World
  • Product Initiative
  • Aimmune Therapeutics, Inc.
  • Genentech Inc, Deals By Therapy Area, 2012 to YTD 2018

This study will have an initial focus on gastrointestinal malignancies, including pancreatic and gastric cancers.

  • Healthcare
  • Immunology
  • Pharmaceutical
  • Therapy
  • Genentech, Inc.
  • UCB SA, Deals By Therapy Area, 2012 to YTD 2018

One such project, led by Dr.

  • Autoimmune Disease
  • Immunology
  • Pharmaceutical
  • United States
  • UCB S.A.

GLASSIA [Alpha ##-Proteinase Inhibitor (Human)] is a liquid, ready-to-use treatment for alpha-## antitrypsin deficiency (AATD).

  • Cardiology
  • Healthcare
  • Immunology
  • Pharmaceutical
  • Baxter International Inc.

## ## ## United States ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## United Kingdom ## ## ## ## ## ## ## France ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## Canada Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database

  • Food Allergy
  • Immunology
  • Therapy
  • World
  • Product Initiative

GLASSIA [Alpha ##-Proteinase Inhibitor (Human)] is a liquid, ready-to-use treatment for alpha-## antitrypsin deficiency (AATD).

  • Cardiology
  • Healthcare
  • Immunology
  • Pharmaceutical
  • Baxter International Inc.

Company type Partner ##: enGene, Inc.

  • Immunology
  • Neurology
  • United States
  • M&A
  • Takeda Pharmaceutical Company Limited

The prominent features of this report are - ##.

  • Clinical Trial
  • Cytokine
  • Immunology
  • Pharmaceutical
  • World

The prominent features of this report are - ##.

  • Drug Discovery And Development
  • Immunology
  • Therapy
  • World
  • Product Initiative

PARTNER ##: JAPAN TOBACCO INC.

  • Healthcare
  • Immunology
  • Neurology
  • Pharmaceutical
  • Merck & Co., Inc.

One unit is one oximeter sensor.

  • Respiratory Monitoring
  • Sensor
  • United States
  • Company
  • GlobalData's company

Company type Partner ##: enGene, Inc.

  • Immunology
  • Neurology
  • United States
  • M&A
  • Takeda Pharmaceutical Company Limited

RedHill will bear part of the drug' s development costs up to $## million.

  • Cardiology
  • Healthcare
  • Immunology
  • Pharmaceutical
  • IntelGenx Corp.

## ## ## ## ## ## ## Danone SA United Pharmaceuticals SAS ## ## ## ## ## ## ## ## ## ## ## ## ## ## DBV Technologies SA ## ## ## ## ## ## ## Danone Research BV ## ## ## ## ## ## ## Biosearch Life ## ## ## ## ## ## ## FrieslandCampina Innovation Interna

  • Food Allergy
  • Immunology
  • Therapy
  • World
  • Product Initiative

The company develops drugs in areas of pain, central nervous system and gastrointestinal disorders.

  • Immunology
  • Pharmaceutical
  • United States
  • M&A
  • Salix Pharmaceuticals, Ltd.

PARTNER ##: JAPAN TOBACCO INC.

  • Healthcare
  • Immunology
  • Neurology
  • Pharmaceutical
  • Merck & Co., Inc.

The prominent features of this report are - ##.

  • Clinical Trial
  • Immunology
  • Pharmaceutical
  • Japan
  • World

The offer is now scheduled to expire on April ##, 2011.

  • Immunology
  • Neurology
  • Pharmaceutical
  • Therapy
  • Genzyme Corporation

ONE UNIT REFERS TO ONE PEAK FLOW METER.

  • Respiratory Monitoring
  • Germany
  • Southern Europe
  • Western Europe
  • Medtronic, Inc.
  • PARTNERSHIP
  • PARTNERSHIP

DEAL IN BRIEF Partner ## Partner ## Deal status Deal category Deal sub-category Date of completion COMPANY INFORMATION: PARTNERS PARTNER ##: F.

  • Healthcare
  • Immunology
  • Pharmaceutical
  • Therapy
  • Becton Property Group
  • PARTNER 3: SANOFI GENZYME
  • PARTNER 3: GLENMARK GENERICS LTD (INACTIVE)

It is headquartered in PARTNER ##: ASTELLAS PHARMA INC.

  • Cardiology
  • Healthcare
  • Immunology
  • Pharmaceutical
  • Glenmark Pharmaceuticals Ltd.
  • PARTNERSHIP - DEAL REPORTS

By using this product, patients can avoid serious gastrointestinal problems.

  • Cardiology
  • Healthcare
  • Immunology
  • Pharmaceutical
  • Valeant Pharmaceuticals International, Inc.